Weight

Insurance plans could cover blockbuster weight-loss medications such as Wegovy and Ozempic, but the benefits may not be accessible to everyone

The new social media trend “budget Ozempic” promotes laxatives and stool softeners for weight loss, but these drugs are dangerous if misused

Clinical-trial data suggest that semaglutide, sold under the name Wegovy, slashed risk of heart attacks and other cardiovascular incidents in a trial

Limited data on adults age 60 and older raise questions on whether high-priced weight-loss drugs will really help with lowering rates of chronic illness and disability

United Nations groups say the artificial sweetener poses a possible risk of liver cancer—but there’s no evidence for harm under the current daily limit

Hormone mimics offer advantages even beyond those of the potent weight-loss shots on the market now

A leading medical society says that the commonly used body mass index falls short, and it is time for alternative measures

A new international study finds that the growth and development benefits of children living in cities may have diminished in the past three decades

A neurologist explains why our bodies fare better when aligned with the natural light of standard time

Weight bias compounds health problems, and surgeons need to recognize and stop it

His brand of misinformation has already tarnished medicine. In the halls of Congress, he’d do much worse

What is living in your gut? It might depend less on your diet, exercise habits, weight and sex than you think, according to new findings. Our health is tied to trillions of organisms that live in and on us.